GUCY1A1
protein-codingguanylate cyclase 1 soluble subunit alpha 1, the group of Soluble guanylate cyclases
Gene summary
Soluble guanylate cyclases are heterodimeric proteins that catalyze the conversion of GTP to 3',5'-cyclic GMP and pyrophosphate. The protein encoded by this gene is an alpha subunit of this complex and it interacts with a beta subunit to form the guanylate cyclase enzyme, which is activated by nitric oxide. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
- GUC1A3
- GUCY1A3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~70.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014331
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014331
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0014331
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Gastrointestinal
Intervention: Cardiovascular
Rationale: Surveillance for cardiovascular complications, as well as related preventive measures to help control contributory factors and clinical manifestations (eg, hypertension) may reduce morbidity and mortality
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GUCY1A1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001130682.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 25 | 3 | 31 | ||
| missense | 1 | 102 | 6 | 2 | 111 | |
| nonsense | 5 | 1 | 6 | |||
| start loss | 0 | |||||
| frameshift | 4 | 3 | 7 | |||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 5 | 9 | ||
| Total | 11 | 7 | 110 | 31 | 5 | 164 |
Highest pathogenic variant AF is 0.000033156015
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001124154.1 | 8 | MANE Select | |
| Ensembl | ENSP00000424361.1 | 8 | MANE Select | |
| RefSeq | NP_000847.2 | 8 | Standard | |
| RefSeq | NP_001124155.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Platelet activation - Homo sapiens (human)
- Oxytocin signaling pathway - Homo sapiens (human)
- Long-term depression - Homo sapiens (human)
- Gap junction - Homo sapiens (human)
- Circadian entrainment - Homo sapiens (human)
Biological Process
- cGMP biosynthetic process
- nitric oxide mediated signal transduction
- blood circulation
- regulation of blood pressure
- positive regulation of nitric oxide mediated signal transduction
Molecular Function
- guanylate cyclase activity
- protein binding
- GTP binding
- heme binding
- signaling receptor activity
Cellular Component
- guanylate cyclase complex, soluble
- glutamatergic synapse
- GABA-ergic synapse
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000296518
- Coding exons
- 8
- Length
- 65639
- Individuals with no LoFs
- 125700
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 47
- Defined
- 125747
- p
- 0.000187
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.681 | 334 | 371 | 0.900 | 0.0000190 | 4549 |
| Missense (PolyPhen) | 108 | 147.21 | 0.73364 | 1814 | ||
| Synonymous | -0.295 | 148 | 144 | 1.03 | 0.00000814 | 1322 |
| Loss of Function | 2.25 | 17 | 30.4 | 0.560 | 0.00000190 | 344 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00044 | 0.00043 | rare |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00022 | 0.00022 | rare |
| South Asian | 0.000099 | 0.000098 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- RVIS EVS
- -1
- RVIS percentile EVS
- 8.47
Essentials
- Essential (gene trap)
- N